Gallium nitrate, "the most potent agent available," approved by FDA for hypercalcemia of cancer
Oncology 5(3): 76
1991
ISSN/ISBN: 0890-9091 PMID: 1829948 Document Number: 381047
Document emailed within 1 workday
Related Documents
Warrell, R.P. 1991: Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia Seminars in Oncology 18(4 Suppl 5): 26-31Harvey, H.A.; Almokadem, S.M. 2004: Hypercalcemia and gallium nitrate Journal of Supportive Oncology 2(6): 516-517
1990: Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients Oncology 4(10): 57-58
Bedikian, A.Y.; Valdivieso, M.; Bodey, G.P.; Burgess, M.A.; Benjamin, R.S.; Hall, S.; Freireich, E.J. 1978: Phase I clinical studies with gallium nitrate Cancer Treatment Reports 62(10): 1449-1453
Collery, P.; Domingo, J.L.; Keppler, B.K. 1996: Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III) Anticancer Research 16(2): 687-691
Apseloff, G.; Girten, B.; Gerber, N.; Shepard, D.R.; Matkovic, V. 1992: Lack of effect of gallium nitrate on bone density in a rat model of simulated microgravity Aviation Space and Environmental Medicine 63(1): 27-31
Saiki, J.H.; Baker, L.H.; Stephens, R.L.; Fabian, C.J.; Kraut, E.H.; Fletcher, W.S. 1982: Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study Cancer Treatment Reports 66(8): 1673-1674
Murphy, T.M.; Geraghty, V.M.; O'Brien, D.J.; O'Sullivan, D. 1986: Use of a colouring agent in approved dips as an aid in identifying dipped sheep Veterinary Record 118(7): 171-173
Dharmani, P.; Mishra, P.Kumar.; Maurya, R.; Chauhan, V.Singh.; Palit, G. 2005: Desmodium gangeticum: a potent anti-ulcer agent Indian Journal of Experimental Biology 43(6): 517-521
Veselý, J.; Cihák, A. 1977: Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice Cancer Research 37(10): 3684-3689
Kikuchi, K.; Tomikawa, S.; Ito, S.; Ichikawa, N.; Ando, Y.; Meigata, K.; Nomura, Y.; Watanabe, K.; Beck, Y.; Degawa, H.; Nagao, T.; Uchida, H. 1996: Prolongation of canine renal allograft survival by a new potent immunosuppressive agent, bactobolamine Transplantation Proceedings 28(3): 1392-1393
Müller, W.E.; Maidhof, A.; Zahn, R.K.; Schröder, H.C.; Gasić, M.J.; Heidemann, D.; Bernd, A.; Kurelec, B.; Eich, E.; Seibert, G. 1985: Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo Cancer Research 45(10): 4822-4826
Dorn, F J. 1984: College counseling center internships: Are APA-approved sites selecting candidates from non-APA-approved training programs? Professional Psychology: Research and Practice 15(2): 131-132
Kobayashi, S.; Hasegawa, K.; Mori, M.; Takagi, H. 1970: Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol) Arzneimittel-Forschung 20(1): 43-46
Hudson, A.T.; Dickins, M.; Ginger, C.D.; Gutteridge, W.E.; Holdich, T.; Hutchinson, D.B.; Pudney, M.; Randall, A.W.; Latter, V.S. 1991: 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients Drugs under Experimental and Clinical Research 17(9): 427-435
Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate Arzneimittel-Forschung 25(10): 1557-1561
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H.; Lenaerts, F.M. 1971: Etomidate, R-(+)-ethyl-1-( -methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats Arzneimittel-Forschung 21(8): 1234-1243
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569
Dhar, J.D.; Setty, B.S.; Duran, S.; Kapil, R.S. 1991: Biological profile of 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran--a potent antiimplantation agent in rat Contraception 44(4): 461-472